Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
51
datasets available to search
ShareScore release 0.9.0
Dataset results
51 results for “chronic GVHD”
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
ClinicalTrials.gov study NCT03112603. IPD Sharing: NO. Countries: 31. Publications: 5.
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
ClinicalTrials.gov study NCT01295710. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Randomized, Controlled, Double-Masked, Clinical Trial of Autologous Serum Eye Drops for Severe Ocular Chronic Graft-versus-Host Disease (GVHD) in Hematopoietic Stem Cell Transplant (HSCT) Patients
ClinicalTrials.gov study NCT01972438. IPD Sharing: NO. Countries: 1. Publications: 3.
Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)
ClinicalTrials.gov study NCT00089141. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Multidisciplinary Intervention In Chronic GVHD
ClinicalTrials.gov study NCT04479995. IPD Sharing: YES. Countries: 1. Publications: 1.
Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD)
ClinicalTrials.gov study NCT01161628. IPD Sharing: NO. Countries: 1. Publications: 8.
Rituximab for Prevention of Chronic GVHD
ClinicalTrials.gov study NCT00379587. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase I Trial of Brentuximab Vedotin for Refractory Chronic Graft-vs.-Host Disease (GVHD)
ClinicalTrials.gov study NCT01940796. IPD Sharing: NO. Countries: 1. Publications: 1.
Chronic GVHD Response Measures Validation
ClinicalTrials.gov study NCT01902576. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Individual Adult and Pediatric Patient Dose-escalated Interleukin-2 Therapy for Refractory Chronic GVHD
ClinicalTrials.gov study NCT02318082. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Improving Outcomes Assessment in Chronic GVHD
ClinicalTrials.gov study NCT00637689. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study
ClinicalTrials.gov study NCT04372524. IPD Sharing: NO. Countries: 2. Publications: 2.
Study of First Line Treatment of Chronic Graft Versus Host Disease With the Association of Ciclosporine, Corticosteroids and Rituximab (Protocol R-GVHD)
ClinicalTrials.gov study NCT01135641. IPD Sharing: Not stated. Countries: 1. Publications: 1.
SHR0302 and Steroid As First Line Therapy for Chronic GVHD
ClinicalTrials.gov study NCT04146207. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I Trial of LDE225 for Steroid-refractory Chronic GVHD After Allogeneic HSCT
ClinicalTrials.gov study NCT02086513. IPD Sharing: NO. Countries: 1. Publications: 1.
Data from: Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans
Allogeneic antibodies against minor histocompatibility antigens encoded on the Y chromosome (HY-Abs) develop after hematopoietic cell transplant (HCT) of male recipients with female donors (F→M). However, the temporal association between HY-Ab development and chronic graft-versus-host disease (cGVHD) has yet to be elucidated. We studied 136 adult F→M HCT patients, with plasma prospectively collected through 3 years posttransplant, and measured immunoglobulin G against 6 H-Y antigens. Multiple HY-Abs were frequently detected beginning at 3 months posttransplant: 78 (57%) of F→M patients were seropositive for at least 1 of the 6 HY-Abs, and 3-month seropositivity for each HY-Ab was associated with a persistent seropositive response throughout the posttransplant follow-up period (P < .001 in each). There were no associations between pretransplant features and 3-month overall HY-Ab development. Detection of multiple HY-Abs at 3 months (represented by HY score) was significantly associated with an increased risk of cGVHD (P < .0001) and nonrelapse mortality (P < .01). Compared to clinical factors alone, the addition of HY score to clinical factors improved the predictive potential of cGVHD (P < .01). Monitoring HY-Ab development thus stratifies cGVHD risk in F→M HCT patients and may support preemptive prophylaxis therapy for cGVHD beginning at 3 months posttransplant.
Itacitinib (INCB039110) and Extracorporeal Photopheresis (ECP) for First-Line Treatment in Chronic GVHD
ClinicalTrials.gov study NCT04446182. IPD Sharing: NO. Countries: 1. Publications: 0.
Campath in Chronic GVHD
ClinicalTrials.gov study NCT00495755. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of orBec® as Monotherapy in the Treatment of Patients With Upper GI Symptoms Caused by Chronic Graft Versus Host Disease (GVHD)
ClinicalTrials.gov study NCT01925950. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD
ClinicalTrials.gov study NCT01163786. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.